Print Friendly, PDF & Email

NCT/Study#

NCT03915951 /

ARRAY-818-202

A Phase 2, Open-Label Study Of Encorafenib + Binimetinib In Patients With BRAFV600E-Mutant Non-Small Cell Lung Cancer

DISEASE GROUP:

Phase 1 Clinical Trials

current phase:

Phase II

STUDY STATUS:

Accepting Patients

Location:

Hackensack, NJ

For More information:

Call 201-518-3587